News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Anzalone Christopher Richard
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/05/2023 |
4
| Anzalone Christopher Richard (CEO) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.|
Txns:
| Sold 54,928 shares
@ $39.14, valued at
$2.1M
Sold 24,008 shares
@ $38.97, valued at
$935.6k
Sold 25,992 shares
@ $40.02, valued at
$1M
Exercised 54,928 options to buy
@ $2.01, valued at
$110.4k
Exercised 50,000 options to buy
@ $2.01, valued at
$100.5k
|
|
| 05/04/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 12/20/2022 |
4
| Anzalone Christopher Richard (CEO) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.|
Txns:
| Granted 18,375 shares
@ $0
Granted 234,025 shares
@ $0 |
|
| 09/29/2022 |
4
| Anzalone Christopher Richard (CEO) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.|
Txns:
| Exercised 39,082 shares
@ $30.77, valued at
$1.2M
Exercised 1,542 shares
@ $31.21, valued at
$48.1k
|
|
| 07/12/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/14/2022 |
4
| Anzalone Christopher Richard (CEO) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.|
Txns:
| Sold 40,853 shares
@ $53.11, valued at
$2.2M
Sold 42,153 shares
@ $52.28, valued at
$2.2M
Sold 61,482 shares
@ $50.9, valued at
$3.1M
Sold 1,900 shares
@ $50.51, valued at
$96k
Exercised 146,388 options to buy
@ $5.19, valued at
$759.8k
|
|
| 01/07/2022 |
4
| Anzalone Christopher Richard (CEO) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.|
Txns:
| Exercised 11,806 options to buy
@ $5.19, valued at
$61.3k
|
|
| 01/04/2022 |
4
| Anzalone Christopher Richard (CEO) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.|
Txns:
| Granted 800,000 shares
@ $0 |
|
| 12/23/2021 |
4
| Anzalone Christopher Richard (CEO) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.|
Txns:
| Exercised 11,806 options to buy
@ $5.19, valued at
$61.3k
|
|
| 12/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/22/2021 |
4
| Anzalone Christopher Richard (CEO) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.|
Txns:
| Sold 15,000 shares
@ $66.23, valued at
$993.5k
Sold 44,170 shares
@ $65.57, valued at
$2.9M
Sold 5,830 shares
@ $66.09, valued at
$385.3k
|
|
| 01/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/30/2020 |
4
| Anzalone Christopher Richard (CEO) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.|
Txns:
| Gifted 1,126 shares
@ $0 |
|
| 12/22/2020 |
4
| Anzalone Christopher Richard (CEO) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.|
Txns:
| Exercised 12,236 options to buy
@ $4.75, valued at
$58.1k
Exercised 28,274 options to buy
@ $6.15, valued at
$173.9k
|
|
| 12/10/2020 |
4
| Anzalone Christopher Richard (CEO) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.|
Txns:
| Sold 16,324 shares
@ $67.97, valued at
$1.1M
Sold 16,726 shares
@ $67.27, valued at
$1.1M
Sold 12,067 shares
@ $69.8, valued at
$842.3k
Sold 5,880 shares
@ $70.87, valued at
$416.7k
Sold 4,003 shares
@ $71.61, valued at
$286.7k
Exercised 16,324 options to buy
@ $2.01, valued at
$32.8k
Exercised 38,676 options to buy
@ $2.01, valued at
$77.7k
|
|
| 10/23/2020 |
4
| Anzalone Christopher Richard (CEO) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.|
Txns:
| Sold 87,728 shares
@ $58.16, valued at
$5.1M
Sold 12,272 shares
@ $58.57, valued at
$718.8k
|
|
| 08/14/2020 |
4
| Anzalone Christopher Richard (CEO) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.|
Txns:
| Sold 50,000 shares
@ $41.35, valued at
$2.1M
Exercised 50,000 options to buy
@ $9.9, valued at
$495k
|
|
| 06/26/2020 |
4
| Anzalone Christopher Richard (CEO) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.|
Txns:
| Sold 99,977 shares
@ $38.81, valued at
$3.9M
Sold 23 shares
@ $39.55, valued at
$909.7 |
|
| 01/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/27/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/13/2019 |
4
| Anzalone Christopher Richard (CEO) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.|
Txns:
| Sold 23,219 shares
@ $66.82, valued at
$1.6M
Sold 58,059 shares
@ $67.31, valued at
$3.9M
Sold 10,343 shares
@ $68.51, valued at
$708.6k
Sold 8,379 shares
@ $69.41, valued at
$581.6k
Sold 8,951 shares
@ $65.85, valued at
$589.4k
Sold 45,577 shares
@ $66.47, valued at
$3M
Sold 25,412 shares
@ $67.3, valued at
$1.7M
Sold 3,393 shares
@ $68.18, valued at
$231.3k
|
|
| 12/04/2019 |
4
| Anzalone Christopher Richard (CEO) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.|
Txns:
| Sold 5,743 shares
@ $66.58, valued at
$382.4k
Sold 7,193 shares
@ $67.63, valued at
$486.5k
Sold 8,510 shares
@ $68.5, valued at
$582.9k
Sold 6,617 shares
@ $69.5, valued at
$459.9k
Sold 2,448 shares
@ $70.72, valued at
$173.1k
Sold 3,800 shares
@ $72.13, valued at
$274.1k
Sold 3,656 shares
@ $72.95, valued at
$266.7k
Sold 4,011 shares
@ $60.73, valued at
$243.6k
Sold 8,022 shares
@ $62, valued at
$497.4k
|
|
| 10/11/2019 |
4
| Anzalone Christopher Richard (CEO) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.|
Txns:
| Sold 56,325 shares
@ $31.83, valued at
$1.8M
Exercised 56,325 options to buy
@ $5.2, valued at
$292.9k
|
|
| 09/27/2019 |
4
| Anzalone Christopher Richard (CEO) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.|
Txns:
| Sold 20,000 shares
@ $28.25, valued at
$565k
|
|
| 09/24/2019 |
4
| Anzalone Christopher Richard (CEO) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.|
Txns:
| Sold 4,250 shares
@ $29, valued at
$123.3k
Sold 41,755 shares
@ $29.04, valued at
$1.2M
Sold 53,972 shares
@ $28, valued at
$1.5M
Sold 12,673 shares
@ $29.04, valued at
$368k
Exercised 4,250 options to buy
@ $5.1, valued at
$21.7k
Exercised 41,755 options to buy
@ $5.1, valued at
$213k
Exercised 66,645 options to buy
@ $5.1, valued at
$339.9k
|
|
| 05/29/2019 |
4
| Anzalone Christopher Richard (CEO) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.|
Txns:
| Exercised 40,072 options to buy
@ $2.01, valued at
$80.5k
Exercised 9,376 options to buy
@ $2.62, valued at
$24.6k
|
|
| 04/05/2019 |
4
| Anzalone Christopher Richard (CEO) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.|
Txns:
| Sold 50,000 shares
@ $19.3, valued at
$965k
|
|
| 01/03/2019 |
4
| Anzalone Christopher Richard (CEO) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.|
Txns:
| Granted 600,000 shares
@ $0 |
|
| 12/21/2018 |
4
| Anzalone Christopher Richard (CEO) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.|
Txns:
| Sold 90,000 shares
@ $13.92, valued at
$1.3M
|
|
| 12/14/2018 |
4
| Anzalone Christopher Richard (CEO) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.|
Txns:
| Sold 90,000 shares
@ $14.07, valued at
$1.3M
|
|
| 11/09/2018 |
4
| Anzalone Christopher Richard (CEO) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.|
Txns:
| Sold 76,200 shares
@ $14.35, valued at
$1.1M
Sold 5,300 shares
@ $14.95, valued at
$79.2k
|
|
| 09/05/2018 |
4
| Anzalone Christopher Richard (CEO) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.|
Txns:
| Sold 100,000 shares
@ $14.45, valued at
$1.4M
Sold 64,834 shares
@ $14.45, valued at
$936.9k
|
|
| 03/16/2018 |
4
| Anzalone Christopher Richard (CEO) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.|
Txns:
| Sold 26,000 shares
@ $7.4, valued at
$192.4k
|
|
|
|
|